Registration Statement No. 333-285508
Filed Pursuant to Rule 424(b)(2)
Amendment No. 29 dated February 9, 2026 to the Pricing Supplement dated December 2, 2020 to the Product Supplement dated December 2, 2020, the Prospectus Supplement dated March 25, 2025 and the Prospectus dated March 25, 2025
Issued by Bank of Montreal
2,500,000 Notes
MicroSectorsTM Gold Miners -3X Inverse Leveraged ETNs due June 29, 2040
This pricing supplement... (continue reading...)
Filed Pursuant to Rule 433 Supplementing the Preliminary Prospectus Supplement Dated February 9, 2026 Registration No. 333-293219
National Bank Holdings Corporation Subordinated Debt Investor Presentation February 2026
Legal Disclaimers Confidentiality This presentation (“Presentation”) contains proprietary and confidential information of National Bank Holdings Corporation and its affiliates (the “Company”) and is provided solely for the purpose of obtaining a... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of February 2026
Commission file number: 001-41760
ParaZero Technologies Ltd.
(Translation of registrant’s name into English)
1 Hatachana Street
Kfar Saba, 4453001, Israel
(Address of principal executive offices)
Indicate by... (continue reading...)
1st Amendment to Registration statement as submitted to the U.S. Securities and Exchange Commission on Feb 06, 2026. This registration statement has been publicly filed with the U.S. Securities and Exchange Commission and all information herein remains strictly confidential.
Registration No. 333-291005
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM F-1/A
AMENDMENT NO. 1 TO THE REGISTRATION STATEMENT
UNDER
THE SECURITIES... (continue reading...)
More SEC Filings
View Older Stories-
Form 497J FT 12718
-
Form 497J FT 12782
-
Form 497J FT 12742
-
Form SCHEDULE 13D/A Commercial Vehicle Group Filed by: Lakeview Opportunity Fund LLC
-
Form 8-K FB Bancorp, Inc. /MD/ For: Feb 09
-
Form 8-K Valaris Ltd For: Feb 09
-
Form SCHEDULE 13G/A Ryerson Holding Corp Filed by: JB CAPITAL PARTNERS LP
-
Form 6-K Diginex Ltd For: Jan 30
-
Form 6-K Energys Group Ltd For: Feb 09
-
Form 6-K ASCENTAGE PHARMA GROUP For: Feb 09
-
Form 8-K TriSalus Life Sciences, For: Feb 03
-
Form 497J FT 12741
-
Form 13F-HR Catalyst Funds Managemen For: Dec 31
-
Form 8-K SYNCHRONOSS TECHNOLOGIES For: Feb 09
-
Form 497J FT 12739
-
Form 424B5 National Bank Holdings
-
Form 13F-HR Fox Financial, Inc For: Dec 31
-
Form SCHEDULE 13G/A Liquidia Corp Filed by: Farallon Capital Partners, L.P.
-
Form 13F-HR Darden Wealth Group Inc For: Dec 31
-
Form 8-K Limitless X Holdings For: Jan 26
-
Form SCHEDULE 13G/A AGIOS PHARMACEUTICALS, Filed by: Farallon Capital Partners, L.P.
-
Form 13F-HR OLD REPUBLIC INTERNATION For: Dec 31
-
Form SCHEDULE 13G/A Revolution Medicines, Filed by: Farallon Capital Partners, L.P.
-
Form SCHEDULE 13G/A LIFETIME BRANDS, INC Filed by: JB CAPITAL PARTNERS LP
-
Form 8-K Nukkleus Inc. For: Feb 09
-
Form 8-K AVANT TECHNOLOGIES INC. For: Feb 03
-
Form TA-2 NORTHEAST INVESTORS TRUS For: Dec 31
-
Form SCHEDULE 13G/A Beta Bionics, Inc. Filed by: Farallon Capital Partners, L.P.
-
Form 3 Entera Bio Ltd. For: Feb 04 Filed by: Germano Geno J
-
Form 6-K VODAFONE GROUP PUBLIC For: Feb 09
-
Form SCHEDULE 13G/A GRAIL, Inc. Filed by: Farallon Capital Partners, L.P.
-
Form SCHEDULE 13G/A Fluent, Inc. Filed by: JB CAPITAL PARTNERS LP
-
Form SCHEDULE 13G/A ASSEMBLY BIOSCIENCES, Filed by: Farallon Capital Partners, L.P.
-
Form 8-K Entera Bio Ltd. For: Feb 04
-
Form 8-K BITMINE IMMERSION TECHNO For: Feb 09
-
Form 8-K Turn Therapeutics Inc. For: Feb 09
-
Form 4 SOUTHERN CO For: Feb 05 Filed by: Poroch David P.
-
Form 4 SOUTHERN CO For: Feb 05 Filed by: Cherry Pedro P.
-
Form 4 SOUTHERN CO For: Feb 05 Filed by: Kim Matthew M.
-
Form 6-K Cadeler A/S For: Feb 09
-
Form 8-K SHF Holdings, Inc. For: Feb 04
-
Form 10-K Ladder Capital Corp For: Dec 31
-
Form 144 Business First Bancshare Filed by: Folse Mark P.
-
Form 8-K LABCORP HOLDINGS INC. For: Feb 06
-
Form 13F-NT Viola Growth Management For: Dec 31
-
Form 497 Brighthouse Life Insuran
-
Form 13F-NT Viola Partners Fund 4 For: Dec 31
-
Form 13F-NT Viola Partners 5 Limited For: Dec 31
-
Form 6-K NOVO NORDISK A S For: Feb 09
-
Form 8-K Ventas, Inc. For: Feb 09

